-
-
-
-
-
-
-
Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache Society
-
-
-
-
-
-
-
Alder BioPharmaceuticals® to Showcase 14 New Data Presentations Demonstrating Eptinezumab’s Migraine Prevention and Quality of Life Impact at American Headache Society Meeting
-
-
-
-
-
-
-
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results
-
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

